• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[The treatment of chronic glomerulonephritis with ultrahigh doses of cyclophosphane].

作者信息

Krasnova T N, Shilov E M, Ivanov A A, Samoĭlov D V, Gordovskaia N B, Miroshnichenko N G, Tareeva I E

出版信息

Ter Arkh. 1991;63(6):115-8.

PMID:1948725
Abstract

Pulse therapy with cyclophosphamide was administered to 44 patients with chronic glomerulonephritis of the nephrotic type with different morphological varieties. The treatment was effective in 59% of cases including 11 out of 24 patients resistant to oral treatment with immunosuppressors. The treatment results were better in patients with normal blood serum creatinine and normal arterial pressure. Remission of the nephrotic syndrome could be observed in mesangioproliferative glomerulonephritis, mesangiocapillary glomerulonephritis, mesangial glomerulonephritis and focal-segmentary hyalinosis. In fibroplastic nephritis, remission of the nephrotic syndrome was recorded in none of the cases. The only prognostically significant sign predicting the treatment effect was the activity index--the totality of the morphological signs reflecting nephritis activity. The sclerotic changes produced no significant effect on the treatment outcome.

摘要

相似文献

1
[The treatment of chronic glomerulonephritis with ultrahigh doses of cyclophosphane].
Ter Arkh. 1991;63(6):115-8.
2
[The catamnestic assessment of the efficacy of combined pathogenetic therapy in patients with different clinico-morphological variants of chronic glomerulonephritis].[慢性肾小球肾炎不同临床-形态学变型患者联合病因治疗疗效的随访评估]
Ter Arkh. 1990;62(6):42-6.
3
[Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
Ter Arkh. 1997;69(6):21-3.
4
[Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
Klin Med (Mosk). 2005;83(10):48-50.
5
[A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
Urol Nefrol (Mosk). 1996 Mar-Apr(2):32-5.
6
[Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].[两种环磷酰胺治疗方案对慢性肾小球肾炎肾病患者的疗效比较]
Ter Arkh. 1998;70(6):14-7.
7
[The prognosis of lupus nephritis during treatment with superhigh-dose cyclophosphane].[超大剂量环磷酰胺治疗期间狼疮性肾炎的预后]
Ter Arkh. 1992;64(8):63-8.
8
[Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].[原发性慢性肾小球肾炎伴肾病综合征。泼尼松和环磷酰胺治疗]
Vnitr Lek. 1993 Dec;39(12):1157-63.
9
[Possibilities for treating patients with the idiopathic nephrotic syndrome].[治疗特发性肾病综合征患者的可能性]
Vutr Boles. 1985;24(4):55-63.
10
[The clinical efficacy of plasmapheresis in the combined therapy of patients with chronic glomerulonephritis and nephrotic syndrome].
Urol Nefrol (Mosk). 1993 Nov-Dec(6):44-6.